Qingxin Kaiqiao Fang Inhibits Aβ(25-35)-Induced Apoptosis in Primary Cultured Rat Hippocampal Neuronal Cells via the p38 MAPK Pathway: An Experimental Validation and Network Pharmacology Study

Qingxin kaiqiao fang (QKF), a traditional Chinese medicine compound, has been applied to treat Alzheimer's disease (AD) for many years and has exhibited remarkable effects. However, the underlying mechanism is still not explicit. The current study aims to investigate whether QKF exerts an antia...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tian-Qi, Lai, Xiao-Xiao, Xu, Lu-Ting, Shen, Yan, Lin, Jian-Wei, Gao, Shi-Yu, Hu, Hai-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424524/
https://www.ncbi.nlm.nih.gov/pubmed/32831882
http://dx.doi.org/10.1155/2020/9058135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424524/
https://www.ncbi.nlm.nih.gov/pubmed/32831882
http://dx.doi.org/10.1155/2020/9058135

Ejemplares similares